Department of Molecular Microbiology and Microbial Pathogenesis, Washington University in St. Louis, Saint Louis, Missouri, USA.
Infect Immun. 2013 Jan;81(1):329-39. doi: 10.1128/IAI.00856-12. Epub 2012 Nov 6.
Urinary catheterization elicits major histological and immunological changes that render the bladder susceptible to microbial invasion, colonization, and dissemination. However, it is not understood how catheters induce these changes, how these changes act to promote infection, or whether they may have any protective benefit. In the present study, we examined how catheter-associated inflammation impacts infection by Enterococcus faecalis, a leading cause of catheter-associated urinary tract infection (CAUTI), a source of significant societal and clinical challenges. Using a recently optimized murine model of foreign body-associated UTI, we found that the implanted catheter itself was the primary inducer of inflammation. In the absence of the silicone tubing implant, E. faecalis induced only minimal inflammation and was rapidly cleared from the bladder. The catheter-induced inflammation was only minimally altered by subsequent enterococcal infection and was not suppressed by inhibitors of the neurogenic pathway and only partially by dexamethasone. Despite the robust inflammatory response induced by urinary implantation, E. faecalis produced biofilm and high bladder titers in these animals. Induction of inflammation in the absence of an implanted catheter failed to promote infection, suggesting that the presence of the catheter itself is essential for E. faecalis persistence in the bladder. Immunosuppression prior to urinary catheterization enhanced E. faecalis colonization, suggesting that implant-mediated inflammation contributes to the control of enterococcal infection. Thus, this study underscores the need for novel strategies against CAUTIs that seek to reduce the deleterious effects of implant-mediated inflammation on bladder homeostasis while maintaining an active immune response that effectively limits bacterial invaders.
导尿会引起主要的组织学和免疫学变化,使膀胱容易受到微生物的侵袭、定植和传播。然而,目前尚不清楚导管如何引起这些变化,这些变化如何促进感染,或者它们是否可能具有任何保护作用。在本研究中,我们研究了导管相关炎症如何影响粪肠球菌(一种导致导管相关尿路感染(CAUTI)的主要病原体)的感染,CAUTI 是一种带来重大社会和临床挑战的疾病。我们使用最近优化的异物相关尿路感染的小鼠模型,发现植入的导管本身是引起炎症的主要原因。如果没有硅酮管植入,粪肠球菌只会引起轻微的炎症,并迅速从膀胱中清除。随后的粪肠球菌感染对导管诱导的炎症仅有轻微改变,并且不能被神经通路抑制剂抑制,仅部分被地塞米松抑制。尽管植入导尿管会引起强烈的炎症反应,但粪肠球菌在这些动物中仍会产生生物膜并导致膀胱内高滴度。在没有植入导管的情况下诱导炎症未能促进感染,这表明导管本身的存在对于粪肠球菌在膀胱中的持续存在是必不可少的。在导尿之前进行免疫抑制会增强粪肠球菌的定植,这表明植入介导的炎症有助于控制粪肠球菌感染。因此,这项研究强调了需要针对 CAUTI 采取新的策略,这些策略既要减轻植入介导的炎症对膀胱内稳态的有害影响,又要维持有效的免疫反应,从而有效限制细菌入侵。